Quality Improvement Initiatives to Assess and Improve PET/CT Injection Infiltration Rates at Multiple Centers.
FDG
PET/CT
extravasation
infiltration
quality improvement
Journal
Journal of nuclear medicine technology
ISSN: 1535-5675
Titre abrégé: J Nucl Med Technol
Pays: United States
ID NLM: 0430303
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
04
03
2019
accepted:
28
05
2019
pubmed:
12
6
2019
medline:
14
4
2020
entrez:
12
6
2019
Statut:
ppublish
Résumé
PET/CT radiotracer infiltration is not uncommon and is often outside the imaging field of view. Infiltration can negatively affect image quality, image quantification, and patient management. Until recently, there has not been a simple way to routinely practice PET radiopharmaceutical administration quality control and quality assurance. Our objectives were to quantify infiltration rates, determine associative factors for infiltration, and assess whether rates could be reduced at multiple centers and then sustained.
Identifiants
pubmed: 31182666
pii: jnmt.119.228098
doi: 10.2967/jnmt.119.228098
pmc: PMC6894099
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
326-331Informations de copyright
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Références
AJR Am J Roentgenol. 2010 Dec;195(6 Suppl):S80-5
pubmed: 21098166
J Nucl Med Technol. 2006 Dec;34(4):193-211; quiz 212-4
pubmed: 17146108
Mol Imaging Biol. 2002 Jul;4(4):276-8
pubmed: 14537117
Oncol Nurs Forum. 1995 Jan-Feb;22(1):57-67
pubmed: 7708525
World J Radiol. 2013 Dec 28;5(12):460-7
pubmed: 24379932
Clin Nucl Med. 1993 Mar;18(3):208-9
pubmed: 8462210
J Nucl Med. 2018 Feb;59(2):273-293
pubmed: 29242396
Clin Nucl Med. 2003 Sep;28(9):786-8
pubmed: 12973012
Indian J Nucl Med. 2011 Oct;26(4):192-3
pubmed: 23559715
Front Med (Lausanne). 2018 Nov 01;5:303
pubmed: 30443549
J Clin Oncol. 2004 Nov 1;22(21):4357-68
pubmed: 15514377
EJNMMI Phys. 2017 Sep 18;4(1):23
pubmed: 28924696
Front Oncol. 2011 Nov 16;1:41
pubmed: 22655246
Clin J Oncol Nurs. 2017 Aug 1;21(4):438-445
pubmed: 28738039
Front Med (Lausanne). 2018 May 15;5:143
pubmed: 29868595
J Nucl Med Technol. 2017 Dec;45(4):267-271
pubmed: 29127247
Med Phys. 2014 May;41(5):052502
pubmed: 24784399
J Nucl Med. 2005 Jun;46(6):983-95
pubmed: 15937310
J Nucl Med. 2009 May;50 Suppl 1:11S-20S
pubmed: 19380405
J Nucl Cardiol. 2017 Aug;24(4):1447-1450
pubmed: 27519643
Nucl Med Commun. 2005 Sep;26(9):827-30
pubmed: 16096587
JAMA Oncol. 2017 May 1;3(5):695-701
pubmed: 28033451
J Biomed Res. 2015 May;29(3):189-202
pubmed: 26060443
Cancer Biother Radiopharm. 2006 Apr;21(2):85-7
pubmed: 16706628
J Nucl Med Technol. 2017 Dec;45(4):265-266
pubmed: 29042469
J Nucl Med. 2001 May;42(5 Suppl):1S-93S
pubmed: 11483694
Nucl Med Commun. 1987 May;8(5):357-63
pubmed: 3684101
J Nucl Med. 2016 Aug;57(8):1316-22
pubmed: 27481605
Semin Oncol. 2011 Feb;38(1):55-69
pubmed: 21362516
J Am Coll Radiol. 2015 Feb;12(2):183-91
pubmed: 25245788
Clin Nucl Med. 2012 Nov;37(11):1115-6
pubmed: 22996243
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2374-2380
pubmed: 27557845